2-hydroxychavicol has been researched along with Glial Cell Tumors in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdul Rahman, A; Harun, R; Jamal, R; Mokhtar, NM; Wan Ngah, WZ | 1 |
| Abdul Rahman, A; Harun, R; Jamal, AR; Mohd Mokhtar, N; Wan Ngah, WZ | 1 |
2 other study(ies) available for 2-hydroxychavicol and Glial Cell Tumors
| Article | Year |
|---|---|
Transcriptome analysis reveals the molecular mechanisms of combined gamma-tocotrienol and hydroxychavicol in preventing the proliferation of 1321N1, SW1783, and LN18 glioma cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromans; Eugenol; Gene Expression Regulation, Neoplastic; Glioma; Humans; Kruppel-Like Factor 4; Vitamin E | 2019 |
Gamma-tocotrienol and hydroxy-chavicol synergistically inhibits growth and induces apoptosis of human glioma cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Chromans; Drug Screening Assays, Antitumor; Drug Synergism; Eugenol; Glioma; Humans; Vitamin E | 2014 |